A Study About the Safety of a Single ASP2020 Eye Injection and if it Helps People With Vision Loss From Stargardt-type Eye Conditions

by | Jul 29, 2026 | Clinical Trials | 0 comments

​ Conditions: Stargardt Disease; Stargardt Macular Dystrophy; Stargardt-like Macular Dystrophy

Interventions: Drug: ASP2020

Sponsors: Astellas Institute for Regenerative Medicine

Not yet recruiting Conditions: Stargardt Disease; Stargardt Macular Dystrophy; Stargardt-like Macular Dystrophy
Interventions: Drug: ASP2020
Sponsors: Astellas Institute for Regenerative Medicine
Not yet recruiting 

Submit a Comment

Your email address will not be published. Required fields are marked *